Hemispherx Biopharma Inc (HEB.A)

HEB.A on American Stock Exchange

0.24USD
19 Dec 2014
Price Change (% chg)

$-0.01 (-2.83%)
Prev Close
$0.25
Open
$0.24
Day's High
$0.25
Day's Low
$0.24
Volume
169,969
Avg. Vol
307,315
52-wk High
$0.55
52-wk Low
$0.22

HEB.A

Chart for HEB.A

About

Hemispherx Biopharma, Inc. (Hemispherx) is a specialty pharmaceutical company engaged in the clinical development of new drugs therapies based on natural immune system enhancing technologies for the treatment of viral and immune based chronic disorders. Hemispherx focuses on two core pharmaceutical technology platforms Ampligen... (more)

Overall

Beta: 1.09
Market Cap (Mil.): $44.61
Shares Outstanding (Mil.): 200.03
Dividend: --
Yield (%): --

Financials

  HEB.A Industry Sector
P/E (TTM): -- 151.49 38.63
EPS (TTM): -0.09 -- --
ROI: -55.23 -0.58 18.27
ROE: -55.33 -1.67 19.14
Search Stocks

Hemispherx to test drugs against Ebola

- Hemispherx Biopharma Inc said it was evaluating two of its drugs against the deadly Ebola virus in collaboration with a unit of the U.S. Department of Defense.

08 Sep 2014

Hemispherx to test drugs against Ebola

Sept 8 - Hemispherx Biopharma Inc said it was evaluating two of its drugs against the deadly Ebola virus in collaboration with a unit of the U.S. Department of Defense.

08 Sep 2014

Competitors

  Price Change
Novartis AG (NOVN.VX) CHF92.35 -1.20
Pfizer Inc. (PFE.N) $31.76 +0.34
Merck & Co., Inc. (MRK.N) $57.75 +0.29
GlaxoSmithKline plc (GSK.L) 1,385.00p 0.00
AstraZeneca plc (AZN.L) 4,555.50p +39.00
Baxter International Inc. (BAX.N) $74.72 +0.27
MediGene AG (MDG1k.DE) €3.80 -0.05

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: New Constructs, LLC
$25.00
Provider: MacroRisk Analytics/EconomicInvestor
$25.00
Provider: S&P Capital IQ Quantitative Report
$115.00
Provider: Pechala's Reports
$15.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks